molecules

A unique collection of 1408 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);

A collection of 747 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening.

A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening；

A unique collection of 683 diabetes related compounds;

A unique collection of 2223 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A unique collection of 904 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;

A unique collection of 614 gut microbial metabolites which can be used for HTS and HCS;

A unique collection of 7234 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1197 stem cell differentiation signaling targeted compounds for high throughput and high content screening;

A collection of 17100 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

A unique collection of 622 natural terpenes and terpenoids can be used for high throughput and high content screening；

A unique collection of 343 protease and proteasome inhibitors for research in chemical genomics, and drug screening;

Well-chosen 1246 compounds with unique structures targeting nervous system;

A unique collection of 2720 kinase inhibitors regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;

A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).

A unique collection of 2808 approved drugs for high throughput screening (HTS) and high content screening (HCS);

3158 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 449 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening；

A collection of 25218 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.

A unique collection of 390 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.

A unique collection of 2938 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc;

A unique collection of 1920 covalent Inhibitors and other molecules with common warheads like chloroacetyl，2-Chloropropionyl，Acryloyl，sulfonyl fluoride, alkyne，acrylamide, ketocarbonyl，disulfide bond, etc.

A unique collection of 246 fragment-like small molecules for FBDD;

A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of 3111 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 210 ubiquitination related small chemicals can be used for high throughput and high content screening；

A unique collection of 534 compounds featuring natural product molecules derived from Miao medicine that can be used for high-throughput and high-content screening.

702 glycometabolism-related comounds, can be used for HTS and HCT;

Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of atherosclerosis, heart failure, myocardial infarction, cancer, infection etc. Antioxidants are a class of compounds that counteract oxidative stress and reduce oxidative damage. The TargetMol Antioxidant Compound Library is a unique collection of 1314 small molecules with inhibitory effects on oxidative stress and is a useful tool for high-throughput screening and high-content screening in the study of oxidative stress.

Well-chosen 338 GPCR targeting compounds with unique structures;

119 tumor-targeted drugs that can be used for high-throughput and high-content screening.

A unique collection of 986 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS.

80 species of cyclic peptide molecules for high-throughput and high-content screening;

1264 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening.

A unique collection of 406 cancer cell differentiation inducing compounds for high throughput and high content screening;

210 macrocyclic compounds of known activity for high-throughput, high-content screening;

Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening.

A unique collection of 263 kinase inhibitors regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.

A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases;

A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 729 compounds targeting NF-κB signaling for high throughput screening and high content screening;

A unique collection of 152 potassium channel blockers and agonists for high throughput and high content screening;

419 well-chosen unique anti-parasitic small molecules;

A unique collection of 531 nuclear receptor signaling targeted compounds for high throughput and high content screening;

For your convenience, there are Diversity Sets of 5,000, 10,000, 15,000, and 20,000 compounds with no structure overlap.

Structurally diverse, medicinally active, and unique chemistry (strong IP potential);

80 well-chosen unique AMPK-targeted small molecules；

A unique collection of 574 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS);

Highly soluble multifunctional fragment library contains 1159 kinds of fragment molecules.

A unique collection of 4720 anti-inflammation compounds effective for high throughput screening and high content screening.